John Burn
John Burn talking at ECCO15-ESMO34 in Berlin about his international study showing that aspirin prevented the development of Hereditary Non-Polyposis Colon Cancer in people genetically at risk for the disease.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Charles Coombes
Charles Coombes at ECCO15-ESMO34 on the Intergroup Exemestane Study showing a big increase in survival for patients with early breast cancer randomized to have their adjuvant therapy switched to exemestane after 2-3 years of tamoxifen, compared with those who remained on tamoxifen for the entire 5 years of endocrine therapy.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Steve Lindsay
In research involving hundreds of houses in the town of Farafenni in The Gambia insect screens covering windows and openings were found to cut the numbers of mosquitoes indoors by 59 per cent. In addition the rates of childhood anaemia related to malaria in the houses being screened were halved in comparison to other homes not screened, according to findings recently published in the journal: The Lancet. Professor Steve Lindsay from the London School of Hygiene and Tropical Medicine discussed the role of such screens for malaria control with Sarah Maxwell.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Ginny Bond
A new “tool-kit” for tackling TB in Zambia is being introduced by researchers working with the London School of Hygiene and Tropical Medicine and the University of Zambia. Ginny Bond tells Peter Goodwin how they are tackling the problem of stigma and TB around Zambia, and how the new “took-kit” brings hope of reducing the pool of TB infection.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Norman Wolmark
Norman Wolmark on the study’s frustrating but unequivocal results showing that bevacizumab did not extend disease-free survival in adjuvant therapy for early colon cancer at 3 years, even though there had been a benefit at 1 year. Also weighing in: Nicholas Petrelli.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Michel Coleman
LONDON—Inequalities in cancer care delivery and overall spending have had a big impact on cancer survival rates in Europe, according to Michel Coleman, Professor of Epidemiology and Vital Statistics at the London School of Hygiene and Tropical Medicine. He gives Peter Goodwin his analysis of data emerging from the Eurocare 4 study in 23 different countries, recently published in the European Journal of Cancer.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.